A Study of OV101 in Individuals With Angelman Syndrome (AS)

NCT04106557 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Disease or Condition Being Studied: Angelman Syndrome (AS)

Interventions

DRUG: Gaboxadol
DRUG: Placebo

Sponsor

Healx AI